Ignite Creation Date:
2024-05-06 @ 3:11 PM
Last Modification Date:
2024-10-26 @ 1:45 PM
Study NCT ID:
NCT04552977
Status:
UNKNOWN
Last Update Posted:
2020-09-17
First Post:
2020-09-14
Brief Title:
A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent Glioblastoma
Sponsor:
Shandong Cancer Hospital and Institute
Organization:
Shandong Cancer Hospital and Institute
Organization Data
Organization:
Shandong Cancer Hospital and Institute
Class:
OTHER
Study ID:
GBM-IIT-SHR3162-TMZ
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shandong Cancer Hospital and Institute
Lead Sponsor Class:
OTHER
Responsible Party:
Jinming Yu
Responsible Party Title:
President of Shandong Cancer Hospital and Institute
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Shandong Cancer Hospital and Institute
Old Name:
None
Old Organization:
None